The latest Vir Biotechnology stock prices, stock quotes, news, and VIR history to help you invest and trade smarter. Vir Biotechnology, Inc. operates as a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies. Get the latest updates on Vir Biotechnology, Inc. Common Stock (VIR) pre market trades, share volumes, and more. Make informed investments with Nasdaq. Vir Biotechnology Inc. ; Next Fiscal Year Estimate, ; Median PE on Next FY Estimate, N/A ; High, $ ; Median, $ ; Low, $ Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the Company will provide financial results for the second quarter ended June 30, , on August 1,
Vir Biotechnology (VIR) has a Smart Score of 7 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund. News. Overview · News · Events & Presentations · Stock Info · Stock Quote · Analyst Coverage · Financials · Quarterly Reports · SEC Filings · Governance. Vir Biotechnology Inc. · · Partner Center · Your Watchlists · Recently Viewed Tickers · VIR Overview · Key Data · Performance · Analyst Ratings. Sell. On average, Wall Street analysts predict that Vir Biotechnology's share price could reach $ by Aug 20, The average Vir Biotechnology stock price. Stock analysis for Vir Biotechnology Inc (VIR:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Vir Biotechnology, Inc. is an immunology company, which is focused on combining cutting-edge technologies to treat and prevent serious infectious diseases. Vir Biotechnology Inc VIR:NASDAQ · Open · Day High · Day Low · Prev Close · 52 Week High · 52 Week High Date06/05/24 · 52 Week Low · Vir Biotechnology, Inc. (US:VIR) has institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). Vir Biotechnology, Inc. (lead-pro-100.ru): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Vir Biotechnology, Inc. | Nasdaq. Vir Biotechnology Inc. · REAL TIME AM EDT 08/29/24 · USD · % · Volume64, An estimate of a stock's true price based on valuation of 49 models like discounted cash flow, peer valuation multiples, and dividend discount models.
Powering the Immune Systemto Transform Lives. Overview, News, Events & Presentations, Stock Info, Stock Quote, Analyst Coverage, Financials, Quarterly Reports. Vir has deep immunology expertise that we are harnessing to address infectious diseases, viral-associated diseases and immune targeting. The average price target is $ with a high forecast of $ and a low forecast of $ The average price target represents a % change from the. Vir Biotechnology Inc. ; Open. ; High. ; 52wk High. ; Volume. k ; Beta. Vir is leveraging immunologic breakthroughs to address unmet patient needs in infectious disease and beyond. NASDAQ: VIR Research Vir Biotechnology's (Nasdaq:VIR) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and. Discover real-time Vir Biotechnology, Inc. Common Stock (VIR) stock prices, quotes, historical data, news, and Insights for informed trading and investment. Vir Biotechnology Inc. ; Volume, M ; Market Value, $B ; Shares Outstanding, M ; EPS (TTM), -$ ; P/E Ratio (TTM), N/A. Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases.
Vir Biotechnology Inc ; Sep, Initiated, Morgan Stanley, Underweight, $15 ; Mar, Upgrade, Robert W. Baird, Underperform → Neutral, $36 → $ Price, $, Volume, , Change, , % Change, %. Today's Open, $, Previous Close, $ Intraday High, $, Intraday Low, $ The current price of VIR is USD — it has increased by % in the past 24 hours. Watch Vir Biotechnology, Inc. stock price performance more closely on the. Why Shares of Vir Biotechnology Rose % This Week Joining the S&P SmallCap could boost the company's profile. Why Vir Biotechnology Stock Is. Shares can be purchased through any registered broker. Vir does not have a direct stock purchase plan. Does Vir pay dividends and have a dividend reinvestment.
Looking for a drug to fight the coronavirus outbreak: Vir Biotechnology CEO
Vir Biotechnology · Market Cap · P/E Ratio (ttm) · Forward P/E · Diluted EPS (ttm) · Dividends Per Share · Dividend Yield · Ex-Dividend Date. Vir Biotechnology Inc. ; Volume, M ; Market Value, $B ; Shares Outstanding, M ; EPS (TTM), -$ ; P/E Ratio (TTM), N/A. Vir Biotechnology, Inc., an immunology company, develops therapeutic products to treat and prevent serious infectious diseases. Vir Biotechnology Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. Vir Biotechnology, Inc.'s stock symbol is VIR and currently trades under NASDAQ. It's current price per share is approximately $
Standby Letter | Best Homeowners Insurance Hawaii